Intermittent Fasting and Kidney Disease

Intermittent fasting and kidney disease is a combination that requires careful consideration before any dietary changes are made. Intermittent fasting involves cycling between defined periods of eating and fasting, and while it has gained popularity for weight and metabolic management, the kidneys play a central role in fluid balance, electrolyte regulation and waste clearance. For people living with chronic kidney disease or other renal conditions, these functions are already compromised, meaning that fasting carries risks that do not apply to the general population. This article explains what the evidence and UK clinical guidance say, and when to seek specialist advice.

Is intermittent fasting safe if you have kidney disease?

Intermittent fasting is not straightforwardly safe for people with kidney disease; risks depend on disease severity and require personalised assessment by a nephrologist or renal dietitian before any fasting is started.

Intermittent fasting is not straightforwardly safe for people with kidney disease, and the level of risk depends heavily on the type and severity of the condition. Intermittent fasting describes a pattern of eating that cycles between defined periods of eating and fasting, with common approaches including the 16:8 method (eating within an eight-hour window) and the 5:2 method (two very low-calorie days per week). While evidence in the general population suggests potential benefits for weight management and metabolic health, the kidneys play a central role in fluid balance, electrolyte regulation and waste clearance, all of which can be disrupted by significant dietary changes.^[3][4]

For people with chronic kidney disease (CKD), the kidneys are already less able to maintain these balances. Prolonged fasting may contribute to dehydration, shifts in potassium and phosphate levels, and increased protein breakdown, each of which can place additional strain on already compromised kidney function.^[5][14] These risks are biologically plausible and are consistent with the principles set out in NICE guideline NG203 on CKD assessment and management, though the direct evidence base from clinical trials in people with CKD remains limited and no large, high-quality trials have established the safety of intermittent fasting across CKD stages.

It is worth noting that many time-restricted eating approaches permit water and other non-caloric fluids during fasting periods. However, people with CKD often have individual fluid prescriptions, meaning that even fluid intake during a fast requires personalised guidance rather than a general rule.

Religious fasting, including fasting during Ramadan, is a common real-world context in which these questions arise. The UK Kidney Association (UKKA) provides specific guidance for people with kidney disease who are considering religious fasting, and early discussion with your renal team before any fasting period is strongly advised.^[5]

Anyone with a kidney condition considering intermittent fasting should discuss this with their nephrologist or renal dietitian before making any changes. A personalised assessment is essential because what may be tolerable at CKD stage 2 may be harmful at stage 4 or 5. Self-directed fasting without professional guidance carries real risks in this population and is not recommended.

Which types of kidney disease carry the highest risk?

Advanced CKD (stages 4 and 5), dialysis patients and kidney transplant recipients carry the highest risk, due to impaired electrolyte regulation, hyperkalaemia risk and the need for consistent medicine timing.

People with advanced CKD (stages 4 and 5), those receiving dialysis, and individuals who have received a kidney transplant carry the highest risk when considering intermittent fasting. At these stages, the kidneys have severely reduced capacity to excrete waste products such as urea and creatinine, and to regulate electrolytes including potassium, phosphate and sodium. Fasting periods can accelerate protein catabolism, raising blood urea nitrogen and worsening uraemic symptoms.

Dialysis patients face particular challenges. Their dietary requirements are tightly managed to account for what the dialysis process removes and what it does not. Fasting can cause fluctuations in potassium and fluid status between dialysis sessions, and hyperkalaemia is a recognised risk in this group that can contribute to cardiac arrhythmias.^[6][18] The UKKA publishes guidance on hyperkalaemia management in adults with CKD and on nutrition for dialysis patients, which renal teams use to inform individual dietary plans.

Transplant recipients take immunosuppressant medicines that typically need to be taken consistently with respect to meal timing, as food can affect absorption.^[8][9] The precise requirements vary by drug, and patients should follow the instructions given by their transplant team or the medicine's patient information leaflet. Fasting that disrupts meal timing may therefore affect drug levels; any planned dietary change should be discussed with the transplant team before it is started.

A practical point relevant to several groups: phosphate binders, which are commonly prescribed in CKD and dialysis, must be taken with food to be effective. Fasting alters meal timing and may therefore affect binder efficacy. If you take phosphate binders, do not adjust their timing without first speaking to your renal dietitian or prescriber.

Other high-risk groups include people with:

• Diabetic nephropathy, where blood glucose management during fasting periods is complex and hypoglycaemia risk is elevated, particularly in those on insulin or sulfonylureas. Diabetes UK provides guidance on fasting, including during Ramadan, for people with diabetes that may be a useful starting point alongside renal team advice.

• Nephrotic syndrome, where protein losses are already significant and further protein breakdown during fasting may worsen hypoalbuminaemia.^[10]

• Polycystic kidney disease (PKD), where research into dietary interventions is at an early and preliminary stage; clinical guidance remains cautious and no firm recommendations for or against fasting can be drawn from current evidence.

• Acute kidney injury (AKI), where nutritional support is often a clinical priority rather than restriction.

Even people with earlier-stage CKD who have comorbidities such as heart failure or type 2 diabetes should approach fasting with considerable caution and specialist input.

What do NHS and NICE guidelines say about fasting with CKD?

NICE NG203 does not specifically endorse or prohibit intermittent fasting in CKD, but emphasises individualised dietary advice from a renal dietitian, making unsupervised fasting inconsistent with its principles.

Neither NICE nor the NHS currently issues specific guidance endorsing or prohibiting intermittent fasting for people with CKD, reflecting the limited and inconsistent evidence base in this population. NICE guideline NG203 (Chronic kidney disease: assessment and management, updated 2023) emphasises individualised dietary advice delivered by a renal dietitian, focusing on managing protein intake, phosphate, potassium, sodium and fluid balance according to the patient's stage of disease and comorbidities.^[1][2] This individualised approach may be difficult to align with the fixed patterns of most popular fasting protocols without careful, personalised adjustment.

NG203 recommends that people with CKD receive dietary advice from a healthcare professional with specialist renal nutrition expertise; the specific staging thresholds and triggers for referral are set out in the guideline itself, and your renal team will apply these to your individual circumstances. The guidance highlights that dietary needs change as kidney function declines, and that unsupervised dietary changes carry risk. While NG203 does not explicitly name intermittent fasting as contraindicated, its principles around protein intake and electrolyte management require careful consideration before any fasting approach is adopted.

The NHS advises people with kidney disease to follow a diet tailored to their specific blood results and kidney function, rather than following general healthy-eating trends without professional review. NHS renal diet guidance covers protein, potassium, phosphate, sodium and fluid management and is available on the NHS website. Renal dietitians generally advise that any significant dietary change, including prolonged fasting or very low-calorie diets, should be assessed individually before being started.

The UKKA also provides specific guidance for patients considering religious fasting, including during Ramadan, and advises early discussion with the renal team.^[5] If you are under the care of a renal team, any planned dietary change should be discussed at your next clinic appointment or by contacting your renal dietitian directly. Do not wait until symptoms arise before seeking advice.

Safer dietary approaches for people living with kidney disease

A renal-specific dietary plan developed with a qualified renal dietitian, focusing on consistent meal timing and managed protein, potassium, phosphate and fluid intake, is the safest evidence-based approach.

A renal-specific dietary plan, developed with a qualified renal dietitian, is the safest and most evidence-based approach to nutrition for people living with kidney disease. Rather than fasting, most renal dietitians focus on consistent, balanced eating patterns that support kidney function without causing harmful fluctuations in waste products or electrolytes. NICE NG203 and UKKA nutrition guidance for adults with CKD both support this individualised, dietitian-led approach.

Key principles of a kidney-friendly diet typically include:

• Protein management: Moderate protein intake is generally advised for people not on dialysis, as excess protein increases the kidneys' workload. Dialysis patients, by contrast, often need higher protein to compensate for losses during treatment. Specific targets vary by CKD stage and individual circumstances and should be set by a renal dietitian. In advanced CKD and dialysis, there is also a risk of protein-energy wasting and sarcopenia, making it important that any calorie or protein restriction is carefully monitored rather than self-directed.^[12][13]

• Potassium control: Depending on blood results, some people with CKD need to limit high-potassium foods such as bananas, tomatoes, potatoes and dried fruit. During prolonged fasting or catabolic states, hyperkalaemia risk in CKD is increased through several mechanisms including reduced insulin-mediated uptake and metabolic acidosis; the UKKA hyperkalaemia guideline provides further detail for clinicians.^[14][6] Any dietary change that could affect potassium levels should be discussed with your renal team.

• Phosphate restriction: Processed foods, dairy and certain wholegrains are high in phosphate. Phosphate additives in processed and convenience foods are also a significant source and are often more readily absorbed than naturally occurring phosphate. Elevated phosphate in CKD contributes to bone disease and cardiovascular risk.^[7][17] If you are prescribed phosphate binders, these must be taken with meals; if fasting changes your meal pattern, discuss binder timing with your renal dietitian or prescriber before making any adjustment.

• Fluid and sodium balance: Fluid restriction is important for many people with advanced CKD or on dialysis. High sodium intake worsens fluid retention and blood pressure. Individual fluid allowances vary and should be confirmed with your renal team.

• Consistent meal timing: Regular meals help maintain stable blood glucose, support medication absorption and avoid the metabolic stress of prolonged fasting.

For people with CKD who also have obesity or type 2 diabetes, weight management remains important, but should be pursued through calorie-controlled, nutritionally complete diets rather than fasting protocols. A renal dietitian can help design a plan that addresses weight and metabolic goals without compromising kidney health.

When should you speak to your kidney specialist before changing your diet?

Speak to your renal team before any significant dietary change if you have a kidney condition at any stage, particularly if you are at CKD stage 3b or above, on dialysis, post-transplant or taking medicines affected by food intake.

You should speak to your kidney specialist or renal dietitian before making any significant dietary change, including starting intermittent fasting, if you have a diagnosed kidney condition at any stage. This conversation is particularly urgent in certain circumstances. Contact your renal team promptly if you are considering a dietary change and any of the following apply:

• You are at CKD stage 3b, 4 or 5.

• You are receiving haemodialysis or peritoneal dialysis.

• You have had a kidney transplant.

• You take medicines whose absorption or safety depends on food intake, including immunosuppressants, insulin or certain blood pressure medicines.

• You take phosphate binders, which must be taken with food and should not be retimed without professional advice.

• You take medicines that carry an increased risk of harm during dehydration or illness, including ACE inhibitors, angiotensin receptor blockers (ARBs), diuretics, SGLT2 inhibitors or NSAIDs. Think Kidneys, a UK programme supporting AKI prevention, provides sick-day guidance on managing these medicines during periods of reduced fluid intake or illness; your renal team can advise on what applies to you.

• You have recently had an episode of acute kidney injury.

• Your most recent blood results showed abnormal potassium, phosphate or urea levels.

If you experience symptoms such as unusual fatigue, muscle cramps, reduced urine output, swelling in the legs or ankles, or nausea during any dietary change, contact your GP or renal team. For symptoms that are severe or rapidly worsening, call 999 or go to your nearest accident and emergency department. For urgent advice that does not require emergency attendance, NHS 111 is available around the clock.

It is also worth noting that GLP-1 receptor agonists are being studied in people with CKD as a potential approach to metabolic and weight management. Research in this area is ongoing and results are preliminary; these medicines are not without risks in people with kidney disease, including gastrointestinal side effects that can contribute to dehydration, which itself carries AKI risk in CKD. Any consideration of weight-management medicines in the context of kidney disease would require close coordination with your renal team. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support; any medicine would only be prescribed where clinically appropriate following a consultation. Always inform every member of your healthcare team of any dietary or medication changes you are considering.

Scientific References

1. Chronic kidney disease: assessment and management (NG203).
2. Chronic kidney disease: assessment and management (NG203) – Recommendations.
3. Intermittent Fasting and Obesity-Related Health Outcomes.
4. Intermittent fasting for weight management and metabolic outcomes.
5. Effects of fasting on patients with chronic kidney disease.
6. Hyperkalaemia – Treatment summaries.
7. Cardiovascular risk in chronic kidney disease (CKD).
8. Effect of time of meal consumption on bioavailability of tacrolimus.
9. Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients.
10. Nephrotic syndrome in children.
11. Association Between Dietary Protein Intake and Kidney Function in Community-Dwelling Older Adults: A Systematic Review.
12. Prevalence and Overlap of Malnutrition, Sarcopenia and Related Nutritional Syndromes in a Large Haemodialysis Population.
13. Combined Assessment of Skeletal Muscle Mass Index and Extracellular-to-Intracellular Water Ratio Predicts Mortality and Health-Related Quality of Life in Hemodialysis Patients.
14. Electrolyte and acid-base balance disorders in advanced chronic kidney disease.
15. Toward Additive-Aware Dietary Guidance in Chronic Kidney Disease: Research Gaps and Future Directions.
16. Is phosphorus intake that exceeds dietary requirements a risk factor in bone health?.
17. Comparative Cardiovascular Outcomes of Lanthanum Carbonate and Sevelamer in Dialysis.
18. Hyperkalemia and the Risks of Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease.
19. SGLT2 inhibitors, semaglutide, and finerenone in diabetic kidney disease: a Bayesian network meta-analysis.
20. Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial.

Frequently Asked Questions